Puma Biotechnology Inc

(PBYI) Trade

By |

Profile

Puma Biotechnology is a biotechnology company focused on developing novel therapeutics for the treatment of cancer. Puma licenses the commercial rights to its current drug candidates. The company expects to augment its product pipeline by acquiring, through license or otherwise, additional drug candidates for research and development and potential commercialization. In evaluating potential drug candidates, Puma employs disciplined decision criteria favoring drug candidates that have undergone at least some clinical study.

Contact Information

Website: www.pumabiotechnology.com
Email: ir@pumabiotechnology.com
Main Phone: +1 424 248-6500
Address: 10880 Wilshire Boulevard
Address 2: Suite 2150
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90024

Issuer Information

Exchange: NGS
CEO: Alan H. Auerbach
Employees: 269
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Puma Biotechnology is a biotechnology company focused on developing novel therapeutics for the treatment of cancer. Puma licenses the commercial rights to its current drug candidates. The company expects to augment its product pipeline by acquiring, through license or otherwise, additional drug candidates for research and development and potential commercialization. In evaluating potential drug candidates, Puma employs disciplined decision criteria favoring drug candidates that have undergone at least some clinical study.

Contact Information

Website: www.pumabiotechnology.com
Email: ir@pumabiotechnology.com
Main Phone: +1 424 248-6500
Address: 10880 Wilshire Boulevard
Address 2: Suite 2150
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90024

Issuer Information

Exchange: NGS
CEO: Alan H. Auerbach
Employees: 269
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 10.26 $ -0.28 (-2.66%)
Last Price 10.26 Change $ -0.28 Change % -2.66 Tick N/A
Bid 10.25 Bid Size 1,700.00 Ask 10.26 Ask Size 200.00
Open 10.56 High 10.63 Low 10.14 Prev Close 10.54
Last Trade Volume 411,564 52 Wk Hi 15.00 52 Wk Low 5.50
Market Cap 403.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,364,379.00 EPS (TTM) -2.12 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 24
Number of Buys 0 8
Number of Sells 1 16
Net Activity -1211 10551
Last 10 Buys Shares
Richard P. Bryce 1,000
Richard P. Bryce 1,000
Thomas R. Malley 1,000
Thomas R. Malley 1,000
Thomas R. Malley 1,000
Last 10 Sell Shares
Charles R. Eyler 1,000
Charles R. Eyler 1,000
Richard P. Bryce 1,000
Steven Lo 1,000
Alan H. Auerbach 1,000
Charles R. Eyler 1,000
Richard P. Bryce 1,000
Richard P. Bryce 1,000
Richard P. Bryce 1,000
Steven Lo 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 146 146 146 146
Low Target Price Estimate 70 70 70 70
Mean Target Price Estimate 100.83 100.83 100.83 100.83
Standard Deviation 27.19 27.19 27.19 27.19
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 4 4 6
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.8 1.67 1.67 1.29